miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner

BACKGROUND: Gastric cancer (GC) is a common malignant disease worldwide. Aberrant miRNAs expression contributes to malignant cells behaviour, and in preclinical research, miRNA targeting has shown potential for improving GC therapy. Our present study demonstrated that miR-632 promotes GC progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ying, Huang, Xiaoxiao, Chen, Guobin, Wang, Ying, Liu, Yuansheng, Xu, Wei, Tang, Shaohui, Guleng, Bayasi, Liu, Jingjing, Ren, Jianlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322242/
https://www.ncbi.nlm.nih.gov/pubmed/30612555
http://dx.doi.org/10.1186/s12885-018-5247-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322242/
https://www.ncbi.nlm.nih.gov/pubmed/30612555
http://dx.doi.org/10.1186/s12885-018-5247-z

Ejemplares similares